258 related articles for article (PubMed ID: 32560646)
1. Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report.
Xu TM; Lin B; Chen C; Liu LG; Xue Y
Virol J; 2020 Jun; 17(1):80. PubMed ID: 32560646
[TBL] [Abstract][Full Text] [Related]
2. The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series.
Zeng H; Wang D; Nie J; Liang H; Gu J; Zhao A; Xu L; Lang C; Cui X; Guo X; Zhou C; Li H; Guo B; Zhang J; Wang Q; Fang L; Liu W; Huang Y; Mao W; Chen Y; Zou Q
Signal Transduct Target Ther; 2020 Oct; 5(1):219. PubMed ID: 33024082
[TBL] [Abstract][Full Text] [Related]
3. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
Duan K; Liu B; Li C; Zhang H; Yu T; Qu J; Zhou M; Chen L; Meng S; Hu Y; Peng C; Yuan M; Huang J; Wang Z; Yu J; Gao X; Wang D; Yu X; Li L; Zhang J; Wu X; Li B; Xu Y; Chen W; Peng Y; Hu Y; Lin L; Liu X; Huang S; Zhou Z; Zhang L; Wang Y; Zhang Z; Deng K; Xia Z; Gong Q; Zhang W; Zheng X; Liu Y; Yang H; Zhou D; Yu D; Hou J; Shi Z; Chen S; Chen Z; Zhang X; Yang X
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9490-9496. PubMed ID: 32253318
[TBL] [Abstract][Full Text] [Related]
5. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
[TBL] [Abstract][Full Text] [Related]
6. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
[TBL] [Abstract][Full Text] [Related]
7. Convalescent plasma to treat COVID-19.
Bloch EM
Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
[No Abstract] [Full Text] [Related]
8. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
Hueso T; Pouderoux C; Péré H; Beaumont AL; Raillon LA; Ader F; Chatenoud L; Eshagh D; Szwebel TA; Martinot M; Camou F; Crickx E; Michel M; Mahevas M; Boutboul D; Azoulay E; Joseph A; Hermine O; Rouzaud C; Faguer S; Petua P; Pommeret F; Clerc S; Planquette B; Merabet F; London J; Zeller V; Ghez D; Veyer D; Ouedrani A; Gallian P; Pacanowski J; Mékinian A; Garnier M; Pirenne F; Tiberghien P; Lacombe K
Blood; 2020 Nov; 136(20):2290-2295. PubMed ID: 32959052
[TBL] [Abstract][Full Text] [Related]
10. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
[TBL] [Abstract][Full Text] [Related]
11. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
[TBL] [Abstract][Full Text] [Related]
12. Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
Rabelo-da-Ponte FD; Silvello D; Scherer JN; Ayala AR; Klamt F
J Infect Dis; 2020 Oct; 222(9):1575-1578. PubMed ID: 32777038
[No Abstract] [Full Text] [Related]
13. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
Farrugia A
Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
[No Abstract] [Full Text] [Related]
14. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
15. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
[TBL] [Abstract][Full Text] [Related]
16. Use of convalescent plasma in COVID-19 patients in China.
Zhu M; Hu K; Zhu Z
Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
[No Abstract] [Full Text] [Related]
17. Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods.
Albahri OS; Al-Obaidi JR; Zaidan AA; Albahri AS; Zaidan BB; Salih MM; Qays A; Dawood KA; Mohammed RT; Abdulkareem KH; Aleesa AM; Alamoodi AH; Chyad MA; Zulkifli CZ
Comput Methods Programs Biomed; 2020 Nov; 196():105617. PubMed ID: 32593060
[TBL] [Abstract][Full Text] [Related]
18. Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles.
Im JH; Nahm CH; Baek JH; Kwon HY; Lee JS
J Korean Med Sci; 2020 Jul; 35(26):e239. PubMed ID: 32627442
[TBL] [Abstract][Full Text] [Related]
19. INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY.
Olivares-Gazca JC; Priesca-Marín JM; Ojeda-Laguna M; Garces-Eisele J; Soto-Olvera S; Palacios-Alonso A; Izquierdo-Vega J; Chacon-Cano R; Arizpe-Bravo D; López-Trujillo MA; Cantero-Fortiz Y; Fernandez-Lara D; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2020; 72(3):159-164. PubMed ID: 32584322
[TBL] [Abstract][Full Text] [Related]
20. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
Zhang L; Pang R; Xue X; Bao J; Ye S; Dai Y; Zheng Y; Fu Q; Hu Z; Yi Y
Aging (Albany NY); 2020 Apr; 12(8):6536-6542. PubMed ID: 32320384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
